1. FRI0084 SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, IMMUNOGENICITY, AND PRELIMINARY EFFICACY OF ROZIBAFUSP ALFA IN SUBJECTS WITH RHEUMATOID ARTHRITIS: INTERIM ANALYSIS OF A PHASE 1B RANDOMIZED, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE CLINICAL TRIAL. (2nd June 2020) Authors: Abuqayyas, L.; Cheng, L.; Mitragotri, D.; Smith, S.; Teixeira Dos Santos, M.; Zhou, Y.; Chindalore, V.; Cohen, S.; Kivitz, A.; Posch, M.; Sullivan, B.; Parnes, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗